Quest Laboratories IPO Date, Details, Allotment, Review

Quest Laboratories Limited is gearing up for its initial public offering (IPO), aiming to raise Rs 43.16 crores through a fresh issue of 44,49,600 shares.

The Quest Laboratories IPO Date will open for subscription on May 15, 2024, and close on May 17, 2024. The company expects to finalize the allotment process by May 21, 2024, with plans to list on the NSE SME on May 23, 2024.

Investors can participate in the Quest Laboratories IPO within a price band of ₹93 to ₹97 per share. The minimum lot size for an application is 1200 shares, requiring a minimum investment of ₹116,400 for retail investors and ₹232,800 for High Net Worth Individuals (HNI), they need to apply for a minimum of 2 lots (2,400 shares).

Know About Quest Laboratories IPO GMP and Subscription to Click Here.

Quest Laboratories IPO Date
Quest Laboratories IPO Date and Review

Refer to Quest Laboratories IPO RHP for more information.

Quest Laboratories IPO Details

Open DateMay 15, 2024
Close DateMay 17, 2024
Listing DateMay 23, 2024
IPO Size44.5 lakh equity shares aggregating up to ₹43.16 Cr.
Fresh IssueAggregating up to ₹42.16 Cr with 44.5 lakh Share fresh Issue
Face Value₹10 per share
IPO Price Band₹93 to ₹97
IPO Listing onNSE SME
Lot Size1200
OFSN.A
Share Offered to RetailNot Less Than 35% of the total issue share
Share Offered to QBINot Less Than 50% of the total issue share
Share Offered to HNINot Less Than 15% of the total issue share

Quest Laboratories IPO Date

IPO Open DateMay 15, 2024
IPO Close DateMay 17, 2024
Basis of AllotmentMay 21, 2024
Initiation of RefundsMay 22, 2024
The credit of SharesMay 22, 2024
Listing DateMay 23, 2024

Quest Laboratories IPO Allotment Status

You can check the allotment status for the Quest Laboratories IPO by following these steps. First, click the link BIGSHARE SERVICES PVT LTD Then, select the IPO Name from the options provided. After that, enter either your Application Number or PAN Number or Demat.

After entering the required information, click submit and view the allotment status of the IPO. This process should be done around the expected date of May 16, 2024.

Know About Quest Laboratories Limited

  • Founded in June 1998, Quest Laboratories Limited is a pharmaceutical company. The company is best in the production of a diverse range of medications including antibiotics, antimalarials, antispasmodics, anti-inflammatories, and more.
  • The company’s market presence extends across twelve states and two union territories in India, including Uttar Pradesh, Madhya Pradesh, Maharashtra, Delhi, and others.
  • Quest Laboratories’ manufacturing facility is situated in Dhar, Madhya Pradesh.
  • Holding prestigious certifications such as WHO Schedule M GMP, GLP, ISO/IEC 17025:2017, and ISO 9001:2015, the company maintains a high standard of quality and compliance.
  • As of December 31st, 2023, Quest Laboratories employs 83 individuals responsible for various aspects of manufacturing operations, including production, quality control, technical support, inventory management, and administrative functions.

Objects of the Issue IPO

The company intends to allocate the Net Proceeds from the Issue towards the following objectives:

  • Financing capital expenditure for acquiring plant and machinery to expand the existing manufacturing facility.
  • Meet the working capital needs of the company.
  • Catering to general corporate purposes.

Quest Laboratories Limited Promoters Holding

The company’s promoters are Mr. Anil Kumar Sabarwal and Ms. Tejaswini Sabarwal.

  • Shareholding Pre-Issue: 90.36%
  • Shareholding Post-Issue: 65.82%

Quest Laboratories Limited Financial Report (Restated)

ParticularsFor the Period / Year ended on (₹ in Lakh)
31st December, 202331st March, 202331st March, 202231st March, 2021
Liabilities5,869.094,664.723,479.861,839.63
Assets5,869.094,664.723,479.861,839.63
Revenue6,217.836,186.605,954.203,043.55
PAT (Profit After Tax)774.93502.85410.5065.50
Net Worth2,277.151,502.21999.38588.84

Key Performance Indicator (KPI) of Quest Laboratories Limited

As of December 31, 2023, Quest Laboratories Limited’s reported revenue of ₹6,217.83 lakhs, PAT of ₹774.93 lakhs, and a Net Worth of ₹2,277.15 lakhs. Key performance indicators include EBITDA of ₹1208.63 lakhs, RoCE of 41.86%, RoE of 34.03%, and RoNW of 34.03%.

ParticularsAs of 31 December 2023
EBITDA1208.63 Lakh, 19.47%
PAT Margin (in %)12.48%
RoCE (%)41.86%
RoE (%)34.03%
RoNW (%)34.03%
EPS4.21 in pre-issue and post-issue EPS is 6.31
PE Ratio23.03 Pre-issue and post-issue is 15.38

Peer Group Comparison with Quest Laboratories Limited

Company NameCMP (₹)Face Value (₹)Basic & Diluted EPS (₹)PE Ratio (times)RoNW (%)NAV per Share (₹)
Quest Laboratories Limited[●]104.66[●]33.47%13.93
Peer Group Of Quest Laboratories Limited
Beta Drugs Limited1300.001019.5766.4319.55%100.12
Alpa Laboratories Limited93.95105.9015.928.59%68.69
Zenith Drugs Limited63.00104.2914.6929.88%14.37

Quest Laboratories Limited IPO Registrar

BIGSHARE SERVICES PRIVATE LIMITED
Office No. S6-2, 6th Floor, Pinnacle Business Park,
Next to Ahura Centre, Mahakali CavesRoad, Andheri East,
Mumbai – 400 093, Maharashtra, India
Tel: 022 – 6263 8200
E-mail: ipo@bigshareonline.com
Investor grievance e-mail: investor@bigshareonline.com
Website: www.bigshareonline.com

Quest Laboratories Limited IPO Book Running Lead Manager

SHRENI SHARES LIMITED (Formerly Known as Shreni Shares Private Limited)
No. 217, Hive 67 Icon, Poisar Gymkhana Road,
Lokmanya Tilak Nagar Poisar, Near Raghuleela Mall,
Kandivali West, Mumbai – 400067, Maharashtra, India.
Telephone: 022 – 2089 7022
E-mail: shrenishares@gmail.com
Investors Grievance e-mail: info@shreni.in
Contact Person: Ms. Tanya Goyal
Website: www.shreni.in

Quest Laboratories Limited Contact

Quest Laboratories Limited
Plot No. 45, Sector III
Pithampur Industrial Area, Pithampur
Dhar – 454775,
Phone: 07292292374
Email: investors@questlabltd.com
Website: https://www.questlabltd.com/

Quest Laboratories IPO Application Form PDF

To download the Quest Laboratories IPO application form click on Application Form Download ASBA IPO Forms PDF.

Broker Review

Quest Laboratories shows strong financial reports on previous. So you may apply.

Disclaimer:

The information provided here, including company data and financial metrics, is for informational purposes only and does not constitute financial advice, investment recommendations, or solicitation to buy or sell securities. Investors should conduct thorough research or consult with financial professionals before making any investment decisions.

FAQs

When is the Quest Laboratories IPO opening for subscription?

The Quest Laboratories IPO will be open for subscription from May 15, 2024, to May 17, 2024.

What is the IPO size and price band?

The IPO size is 44.5 lakh equity shares aggregating up to ₹43.16 Cr, with a price band of ₹93 to ₹97 per share.

How can I check the allotment status of the IPO?

You can check the allotment status by visiting the website of BIGSHARE SERVICES PVT LTD and entering your Application Number or PAN Number or Demat.

Rate this post

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top